# PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

> **NCT04538950** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PET/CT
- **DRUG:** radioactive drug (tracer)

## Key facts

- **NCT ID:** NCT04538950
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-14
- **Primary completion:** 2022-05-19
- **Final completion:** 2022-05-19
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04538950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04538950, "PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04538950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*